Alpha Tau Medical Ltd (DRTS)

NASDAQ
11.600
-0.280(-2.36%)
After Hours
11.550
-0.050(-0.431%)
- Real-time Data
  • Volume:
    17,368
  • Day's Range:
    11.550 - 11.960
  • 52 wk Range:
    4.684 - 20.650

DRTS Overview

Prev. Close
11.88
Day's Range
11.55-11.96
Revenue
-
Open
11.8
52 wk Range
4.684-20.65
EPS
0.16
Volume
17,368
Market Cap
776.89M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
218,331
P/E Ratio
59.80
Beta
-
1-Year Change
19.83%
Shares Outstanding
66,973,188
Next Earnings Date
Aug 31, 2022
What is your sentiment on Alpha Tau Medical?
or
Market is currently closed. Voting is open during market hours.

Alpha Tau Medical Ltd Company Profile

Alpha Tau Medical Ltd Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy